Publication Name	世界华人消化杂志
手稿编号	36385
手稿来源省、自治区或特别行政区	辽宁省

Received	2018-09-16 06:04
Peer-Review Started	2018-09-17 00:47
To Make the First Decision	2018-09-26 07:59
Return for Revision	2018-09-28 09:38
修回稿	2018-10-26 12:22
Second Decision	2018-11-08 09:10
期刊总编辑接受
公司总编辑接受	2018-11-09 00:20
预出版	2018-11-09 00:20
缴纳版面费
Edit the Manuscript by Language Editor
排版	2019-01-04 09:29
在线出版	2019-01-08 08:50

ISSN	1009-3079 (print) and 2219-2859 (online)
开放获取	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
版权	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
网址	http://www.wjgnet.com

专业类型	消化内科学
手稿栏目类型	述评
文章标题	特利加压素治疗肝肾综合征的循证医学依据
手稿来源	约稿
所有作者列表	张晶巧, 吴云海, 祁兴顺
基金项目及其编号
通讯作者	祁兴顺, 博士, 副主任医师, 110840, 辽宁省沈阳市沈河区文化路83号, 沈阳军区总医院消化内科消化内科. xingshunqi@126.com
关键词	特利加压素; 肝肾综合征; 肝硬化; 去甲肾上腺素; 临床试验
核心内容提要	目前, 血管活性药物联合白蛋白是肝肾综合征(hepatorenal syndrome, HRS)的主要药物治疗手段. 循证医学证据显示,特利加压素联合白蛋白可有效改善HRS患者的肾功能.
出版日期	2019-01-08 08:50
引文著录	张晶巧, 吴云海, 祁兴顺. 特利加压素治疗肝肾综合征的循证医学依据. 世界华人消化杂志 2018
URL	https://www.wjgnet.com/1009-3079/full/v27/i1/1.htm
DOI	https://dx.doi.org/10.11569/wcjd.v27.i1.1

Full Article (PDF)	WCJD-27-1.pdf
审稿意见	WCJD-36385-Peer-review(s).pdf
科学编辑工作清单	WCJD-36385-Scientific editor work list.pdf